Bioventus Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Bioventus Inc. (BVS) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-0.32-316.82-158.7019.3816.41
Depreciation & Amortization49.5657.3729.9720.4728.64
Deferred Income Tax-5.39-2.38-46.66-9.76-0.51
Stock Based Compensation10.062.7217.5919.840.00
Change in Working Capital-11.78-3.18-29.73-15.1515.31
Change in Accounts Receivable-10.6710.06-17.67-20.05-3.94
Change in Inventory-16.44-5.99-18.623.18-0.53
Change in Accounts Payable0.00-5.28-3.1018.2120.51
Change in Other Working Capital15.322.439.66-16.49-0.73
Other Operating Activities-3.332.43-8.76-25.809.53
Net Cash from Operating Activities38.8015.34-13.5422.9971.80
Investing Activities
Capital Expenditures-1.01-7.36-11.52-13.52-16.58
Acquisitions0.000.72-104.84-262.870.00
Purchases of Investments0.000.000.00-7.37-4.09
Sales/Maturities of Investments0.000.000.00-13.520.00
Other Investing Activities23.97-11.51-104.92-13.520.17
Net Cash from Investing Activities22.9615.81-116.44-283.76-20.50
Financing Activities
Debt Repayment-59.58-87.26-45.04-111.25-59.00
Common Stock Issued2.440.785.82109.410.00
Common Stock Repurchased0.000.00-3.350.000.00
Dividends Paid0.000.000.00-0.37-19.89
Other Financing Activities2.56-4.17-0.02-2.240.32
Net Cash from Financing Activities-54.58-26.6562.08273.37-29.57
Summary
Effect of Forex Changes on Cash-2.560.630.52-0.230.59
Net Change in Cash4.624.50-67.3812.3722.32
Cash at Beginning of Period36.9631.8499.2186.8464.52
Cash at End of Period41.5836.9631.8499.2186.84
Free Cash Flow37.797.98-25.069.4755.22
Supplemental Disclosures
Interest Paid38.5132.4718.045.847.49
Income Taxes Paid1.342.961.527.461.54